Chinese health care giant Fosun Pharma has secured a deal with Bio NTech to buy 100 million doses of their coronavirus vaccine for use and distribution in mainland China . 
The deal will be subject to Chinese regulatory approval , Fosun Pharma said in a statement on Wednesday . 
" A local Phase 2 clinical trial of m RNA COVID 19 vaccine candidate BNT162b2 is on going in Jiangsu , China , " the statement said . 
The initial supply of these vaccines will be produced in Bio Ntech â€™s production facilities in Germany . 
The Bio NTech vaccine , developed globally with Pfizer , has already received emergency use authorization in the United States and United Kingdom . 
